# Context Therapeutics (CNTX) — Analyst Forecast

CNTX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cntx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 9 | 1 | 0 | 10 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Jun 16, 2026 | Maxim Group | Maintained | Buy | $4.00 |
| Mar 24, 2026 | Piper Sandler | Maintained | Overweight | $7.00 |
| Mar 24, 2026 | Guggenheim | Maintained | Buy | $5.00 |
| Mar 24, 2026 | D. Boral Capital | Maintained | Buy | $9.00 |
| Dec 22, 2025 | Jones Trading | Initiated Coverage | Buy | $7.00 |
| Nov 6, 2025 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Nov 6, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |
| Oct 16, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |
| Oct 2, 2025 | Cantor Fitzgerald | Initiated Coverage | Overweight | — |
| Sep 18, 2025 | Guggenheim | Initiated Coverage | Buy | $5.00 |
| Aug 7, 2025 | HC Wainwright & Co. | Maintained | Buy | $4.00 |
| Aug 7, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |
| Jun 26, 2025 | Piper Sandler | Maintained | Overweight | $4.00 |
| May 8, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |
| Apr 29, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |
| Apr 21, 2025 | William Blair | Initiated Coverage | Outperform | — |
| Apr 9, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |
| Mar 21, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |
| Mar 21, 2025 | HC Wainwright & Co. | Maintained | Buy | $5.00 |
| Jan 15, 2025 | D. Boral Capital | Maintained | Buy | $9.00 |

## Frequently Asked Questions

### Is CNTX a buy, sell, or hold?

Analysts covering Context Therapeutics currently average a Buy rating: 9 buy, 1 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on CNTX?

On Jun 16, 2026, Maxim Group maintained Context Therapeutics at Buy with a price target of $4.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).